Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 3 | Mind Blowing Facts

CrowdStrike To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

HIMS Stock Just Got Rocked (Again) By the FDA. This Analyst Still Thinks Hims & Hers Can Surge 50%.

Despite a sharp selloff after the latest FDA warning, Hims & Hers continues to post triple-digit annual gains and strong revenue growth, with at least one analyst projecting a 50% upside.

Barchart

Fiverr Surges As Restructuring Promises Millions In Savings

Fiverr International (NASDAQ:FVRR) shares climbed more than 9% on Friday, as investors viewed the stock’s valuation as attractive following its second-quarter earnings report. The company’s recent restructuring initiatives are expected to deliver roughly $30 million in cost savings, further boosting sentiment.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Darden Restaurants Posts Q1 Sales Beat, Analysts Cut Price Target On Profitability Concerns

Shares of Darden Restaurants Inc (NYSE:DR) tanked in early trading on Friday, after the company reported downbeat first quarter results.

Benzinga

Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Apple To Rally More Than 28%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

AppLovin Sees Stronger Non-Gaming Momentum As Expansion Accelerates

AppLovin Corporation’s (NASDAQ:APP) push beyond gaming is gaining momentum, with surging non-gaming revenue fueled by international expansion, referral program adoption, and seasonal ad spend, strengthening the company’s position as it eyes broader opportunities across commerce, healthcare, and financial services.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

AppLovin To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Large Patient Population Is Key Driver For Bright Minds' Growth

BTIG initiated coverage on Bright Minds Biosciences Inc. (NASDAQ:DRUG), a clinical-stage company focused on neurological and psychiatric disorders.

Benzinga

Gitlab Analysts Praise Strong Revenue But Caution On Guidance

Investor sentiment around tech stocks remains volatile as companies navigate changing market dynamics and investor expectations. Amid this backdrop, Gitlab Inc.‘s (NASDAQ:GTLB) recent financial performance and strategic adjustments highlight the challenges and opportunities facing tech firms today.

Benzinga

Analysts Love This Drone Stock. Should You Buy Shares on the Dip?

Analysts love AIRO Group. But as the stock is new on Wall Street, should you consider investing in it?

Barchart

Micron To Rally More Than 49%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

SoFi Stock Is Tearing Higher After Q2 Earnings. Is It Too Late to Buy SOFI Here?

SoFi is flying high after Q2 results. But with dilution drama and a hot valuation, should investors still buy the fintech stock?

Barchart

Ralph Lauren To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

As SoFi Raises 2025 Guidance, Should You Buy, Sell, or Hold SOFI Stock Here?

SoFi stock rallies as the fintech reports a strong Q2 and raised guidance for the full year. Investors are still recommended practicing caution in buying SOFI shares.

Barchart

Crypto Week Is Here. Should You Buy MicroStrategy Stock?

MicroStrategy stock inches up following SEC filings that confirmed the company loaded up on more than 4,000 bitcoins. Crypto week could push MSTR shares up further.

Barchart

This Red-Hot Drone Stock Just Got a $2.7 TRILLION Boost

This article highlights a rapidly rising drone company that has received a major $2.7 trillion boost in its industry growth outlook.

Barchart

These 3 Stocks Have Been Hot in 2025. Should You Sell Them Now Before It’s Too Late?

BTIG has flagged these stocks as overstretched, and it believes taking profits before the momentum potentially cools off is a smart idea.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cracking The Code: Understanding Analyst Reviews For Stryker

Ratings for Stryker (NYSE:SYK) were provided by 19 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Analyst Ratings For Expedia Group

20 analysts have shared their evaluations of Expedia Group (NASDAQ:EXPE) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

What 19 Analyst Ratings Have To Say About Exact Sciences

19 analysts have shared their evaluations of Exact Sciences (NASDAQ:EXAS) during the recent three months, expressing a mix of bullish and bearish perspectives.

Barchart

Here's How High MicroStrategy Stock Can Climb as Bitcoin Races to New Highs

In the past five years, MicroStrategy's massive exposure to Bitcoin has allowed share prices to surge over 2,000%. Can the tech stock continue to surge in 2025?

Barchart

Wall Street is Overlooking This Penny Stock, Says Analyst

This penny stock could surge up to 200%, according to one bull, who has high hopes for a pipeline drug ahead of trial data due out in 2025.

Barchart

3 Outperforming Stocks to Buy With $500 Right Now

With a budget of around $500, investors can scoop up these three standout stock picks, which have outperformed the broader market in the past year.

Barchart

Should You Buy the Dip in CrowdStrike After the Massive Microsoft Outage?

Despite a significant drop in the shares from its recent high-profile IT glitch, CrowdStrike’s strong fundamentals and growth trajectory make it a potential buy. Don’t miss the chance to grab this dip.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.